Pegasus Biologics Announces Facility Expansion

Business Wire, Oct 21, 2008

Leading Developer of Collagen Scaffolds for Orthopedic Procedures and Wound Management Responds to Steady Growth

IRVINE, Calif. -- Pegasus Biologics, Inc., a privately held developer of collagen scaffolds for soft tissue repair and wound care management, announced today plans to expand its national sales force and manufacturing facilities at its corporate headquarters in Irvine, California.

Michael D. Will, Pegasus Biologics' President and CEO, said, "I am pleased that Pegasus continues to exhibit impressive growth. To keep pace with the increasing demand for our products worldwide and to accommodate new products on the horizon, we have enhanced both our sales organization and our Irvine, California facility. By strengthening our sales force, manufacturing and research capabilities, we will be well positioned to maintain a leadership role in both the orthopedics and wound management markets well into the future."

Keith Myers, Vice President of Operations, added, "The expansion of our facility at our headquarters in Irvine to nearly 21,000 sq feet is impressive for a young Company such as Pegasus Biologics. I am amazed at the rapid growth we have experienced over the last four years since our Company's inception. This expansion will enable Pegasus to reach our next stage of projected growth. Plus, new state of the art laboratories will facilitate our product development efforts and clinical education programs."

Pegasus Biologics, Inc. has the exclusive rights to unique patented technologies related to the stabilization and sterilization of biologic tissue and collagen scaffolds. The Company currently manufactures and markets the OrthADAPT[R] Bioimplant for the surgical implantation to support the repair and reinforcement of soft tissue in orthopedic procedures and the Unite[R] Biomatrix collagen dressing for advanced wound management.

For more information regarding Pegasus Biologics, Inc. or this press release, please contact Michael Will at 949.502.3240 x 201.

About Pegasus Biologics, Inc.

Pegasus Biologics, Inc. (Irvine, CA) is a privately held company focused on the research, development, and commercialization of next generation biologics utilizing the Company's unique and patented technologies. Additional information on the Company can be found at www.pegasusbio.com